Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist-Reference-Cited by-同舟云学术

Recognition and Management of Toxic Erythema of Chemotherapy for the Inpatient Dermatologist

Published:2021-09-30 Issue:4 Volume:10 Page:222-231
ISSN:2162-4933
Container-title:Current Dermatology Reports
language:en
Short-container-title:Curr Derm Rep

Author:

Lee Nari,Zheng Lida^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

https://link.springer.com/content/pdf/10.1007/s13671-021-00344-3.pdf

Reference54 articles.

1. Bolognia JL, Cooper DL, Glusac EJ. Toxic erythema of chemotherapy: a useful clinical term. J Am Acad Dermatol. 2008;59(3):524–9.

2. Horn TD. Antineoplastic chemotherapy, sweat, and the skin. Arch Dermatol. 1997;133(7):905–6.

3. Jacobi U, Waibler E, Schulze P, et al. Release of doxorubicin in sweat: first step to induce the palmar-plantar erythrodysesthesia syndrome? Ann Oncol. 2005;16(7):1210–1.

4. Martschick A, Sehouli J, Patzelt A, et al. The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia. Anticancer Res. 2009;29(6):2307–13.

5. •• Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, et al. Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation. Hematol Oncol Stem Cell Ther. 2019;12(1):19–25. Retrospective analysis of 40 stem cell transplant patients with suspected toxic erythema of chemotherapy. Presented a clinical spectrum and histopathological examples of toxic erythema of chemotherapy, and summarized criteria necessary for diagnosis.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxic Skin Reactions Should Be Differentiated from Allergic Reactions to Chemotherapeutic Drugs in Children: A Case Series and Review of the Literature;Dermatitis®;2024-06-01